Receptors for neuropeptide Y, gamma-aminobutyric acid and dopamine differentially regulate Ca2+ currents in Xenopus melanotrope cells via the G(i) protein beta/gamma-subunit

Gen Comp Endocrinol. 2006 Jan 15;145(2):140-7. doi: 10.1016/j.ygcen.2005.08.006. Epub 2005 Oct 7.

Abstract

Secretion of alpha-melanophore-stimulating hormone (alphaMSH) from pituitary melanotrope cells of the amphibian Xenopus laevis is under inhibitory synaptic control by three neurotransmitters produced by the suprachiasmatic nucleus: gamma-aminobutyric acid (GABA), neuropeptide Y (NPY) and dopamine (DA). These inhibitory effects occur through G(i)-protein-coupled receptors (G(i)PCR), and differ in strength: GABA(B)-receptor-induced inhibition is the weakest, whereas DA (via a D2-receptor) and NPY (via a Y1-receptor) strongly inhibit, with NPY having a long-lasting effect. Previously it was shown that DA inhibits two (R- and N-type channel) of the four voltage-operated Ca2+ channels in the melanotrope, and that only part of this inhibition is mediated by beta/gamma-subunits of the G(i) protein. We here demonstrate that also the Y1- and GABA(B)-receptor inhibit only part of the total Ca2+ current (I(Ca)), with fast activation and inactivation kinetics. However, GABA(B)-mediated inhibition is weaker than the inhibitions induced via Y1- and D2-receptors (-21 versus -27% and -30%, respectively). Using a depolarizing pre-pulse protocol it was demonstrated that GABA(B)-induced inhibition of I(Ca) most likely depends on Gbeta/gamma-subunit activation whereas Y1- and D2- induced inhibitions are only partially mediated by Gbeta/gamma-subunits. No differences were found between the Y1- and D2-induced inhibitions. These results imply that activation of different G(i)PCR inhibits the I(Ca) through different mechanisms, a phenomenon that may underlie the different potencies of the suprachiasmatic neurotransmitters to inhibit alphaMSH secretion.

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Baclofen / pharmacology
  • Calcium / metabolism*
  • Calcium Channels / physiology
  • Cells, Cultured
  • Dopamine Agonists / pharmacology
  • Electric Conductivity
  • GABA Agonists / pharmacology
  • GABA-B Receptor Agonists
  • GTP-Binding Protein alpha Subunits, Gi-Go / metabolism
  • GTP-Binding Protein beta Subunits / physiology*
  • GTP-Binding Protein gamma Subunits / physiology*
  • Melanocyte-Stimulating Hormones / metabolism
  • Neuropeptide Y / pharmacology
  • Patch-Clamp Techniques
  • Pituitary Gland / cytology*
  • Receptors, Dopamine D2 / agonists
  • Receptors, Dopamine D2 / physiology*
  • Receptors, G-Protein-Coupled / physiology
  • Receptors, GABA-B / physiology*
  • Receptors, Neuropeptide Y / agonists
  • Receptors, Neuropeptide Y / physiology*
  • Xenopus laevis / anatomy & histology
  • Xenopus laevis / metabolism*

Substances

  • Calcium Channels
  • Dopamine Agonists
  • G-protein Beta gamma
  • GABA Agonists
  • GABA-B Receptor Agonists
  • GTP-Binding Protein beta Subunits
  • GTP-Binding Protein gamma Subunits
  • Neuropeptide Y
  • Receptors, Dopamine D2
  • Receptors, G-Protein-Coupled
  • Receptors, GABA-B
  • Receptors, Neuropeptide Y
  • neuropeptide Y-Y1 receptor
  • Melanocyte-Stimulating Hormones
  • GTP-Binding Protein alpha Subunits, Gi-Go
  • Baclofen
  • Apomorphine
  • Calcium